David R. Holmes Jr, MD
Articles
August 11th 2010
Clinical and Economic Outcomes After Introduction of Drug-Eluting Stents
Charanjit S. Rihal, MD, MBA James L. Ryan, MHA Mandeep Singh, MBBS Ryan J. Lennon, MS John F. Bresnahan, MD Juliette T. Liesinger, BA Bernard J. Gersh, MBChB, DPhil Henry H. Ting, MD, MBA David R. Holmes Jr, MD Kirsten Hall Long, PhD
Introduction of drug-eluting stents resulted in improved clinical outcomes for patients and reduced overall procedural costs.
Latest Updated Articles
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 20th 2024 | Updated: November 8th 2024
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
